Neuro
Founders

Implantable MEMS‑based directional deep brain stimulation (DBS) system improving precision and outcomes in Parkinson’s and essential tremor.

A wearable “touch therapy” device using calming vibrations to enhance stress resilience, focus, and sleep via SmartVibes AI.

Accelerating precision neuroscience in clinical trials by capturing and analyzing sleep EEG with AI-powered biomarkers.

Developer of the Utah Array, the first FDA-cleared BCI implant, enabling long-term neural recording and brain-controlled devices.

Visualizing users' MRI scans in 3D and delivers personalized brain health insights—including brain age and lifestyle recommendations.

Delivering high-channel-count silicon neural probes and ultra-small headstages enabling artifact-free electrophysiology and optogenetics.

Delivering real-time AI-driven MRI workflows, detecting brain infarcts, hemorrhages, and tumors mid-scan to adapt protocols and prioritize urgent cases.

Providing AI-powered tools (Canvas Dx) for rapid, equitable autism diagnosis in young children, and is developing digital therapeutics to improve behavioral health

Developing the CL1 'biocomputer', a silicon-embedded, lab-grown neuron platform (SBI) that learns via real-time neural code execution.

Building portable, affordable AI-powered MRI systems,
delivering high-quality brain imaging at 20× lower cost, weight, and infrastructure needs.

Combining MRI-compatible EEG cap with AI to pinpoint epileptic zones via simultaneous EEG–fMRI recordings, improving diagnosis precision.

Unlocking voice as a predictive biomarker using AI to detect diseases and support digital diagnostics and therapies across Longevity and neurodegeneration.

Delivering a portable tDCS headset that gently stimulates the prefrontal cortex to relieve depression symptoms, med-free, at-home therapy.

Empowers AI with emotional intelligence, creating empathic speech capabilities and measuring nuance in voice, text, and facial expression.

Providing fNIRS neuroimaging (Flow) for high-density brain monitoring targeting research and potential BCI applications in cognition and health.

Developing Magnetic Particle Imaging (MPI) systems enabling high-sensitivity preclinical imaging and advancing into clinical diagnostics.

Offering a portable fNIRS-based neurofeedback headband and app to help users train their prefrontal cortex for improved focus, stress relief, and mood.

Offering wearable EEG and EMG biosensing devices and SDK for neural interface development, neurofeedback, rehabilitation, and research applications.

Building brain-driven prosthetic control via AI-decoded neural signals, translating amputees’ brainwaves into intuitive limb movement.

Developing BCI-enabled headphones and AI-driven platforms that turn brain signals into control and cognitive insight via everyday wearables.

Developing wearable bioelectronic devices combining micro-electrodes and stimulation to relieve PCOS symptoms and enhance personalized chronic care.

Offerign a wearable, drug-free headband that stimulates and tracks brain activity for managing ADHD symptoms in just 20 minutes daily.

Producing wearable, non-invasive near-infrared light helmets that enhance memory, focus, sleep, and cognitive wellness through photobiomodulation.

Developing ultra-soft, foldable neural implants and AI-driven decoding to monitor and modulate brain activity for epilepsy, tinnitus, and rehab.

Developing NeuromarkR, a brain-sensor platform that measures and tracks craving-related neural biomarkers to personalize addiction treatment and prevent relapse.

Offering Xen, a wearable headphone system that delivers gentle transcutaneous vagus nerve stimulation to reduce stress, improve sleep, and boost focus.

Ear-EEG smartbuds and data platform for continuous brain monitoring focused on sleep, epilepsy and cognitive health.

Developing the Connexus, a fully implantable, high–data-rate BCI that records single-neuron brain signals to restore communication in paralyzed patients.

Developing the Layer 7 Cortical Interface, a minimally invasive, high-resolution brain–computer implant to restore communication and independence via thought.

Developing implantable spinal cord stimulation systems (Avantis) that restore voluntary upper-limb movement in chronic stroke survivors.

Pioneering a wearable brain-first neurotechnology, Nettle, that provides non-hormonal brain stimulation to reduce menstrual pain, low mood, and brain fog.

Developing Clotild, a smart guidewire using impedance-based microsensors and AI to characterize vascular tissue and aid intraoperative decision-making in stroke treatment.

Providing a portable tDCS-based neuromodulation system for depression and chronic pain, enabling remote clinician management and scalable home treatment.

Developing the first non-surgical, nanoparticle-based bidirectional BCI, enabling precise brain stimulation and recording without surgery.

Developing the Stentrode, an endovascular, minimally invasive BCI implant enabling paralyzed individuals to control digital devices using thought alone.

Developing at-home photobiomodulation headsets and applicators that use near-infrared light to support cognitive enhancement, mood, sleep, and overall brain wellness.

Developing Cerebro, a minimally invasive endovascular brain access platform that enables treatment of neurological disorders without drilling through the skull.

Developing Woebot, an AI-powered conversational agent delivering evidence-based, text-based therapy via CBT, IPT, and DBT to democratize mental healthcare.

Developing precision psychiatric medicines by leveraging neurobiology to predict and improve treatment response.

Delivering clinical-grade, non-invasive speech analytics to assess neurological health and monitor neurodegenerative diseases.

Advancing precision medicine by interpreting the nervous system’s real-time data using AI-driven neural interfaces.

Delivering wearable, dry-electrode EEG headbands and SDKs for real-time brain-state monitoring in wellness, gaming, and neurofeedback.

Generating personalized, AI-based connectome maps from MRI (VoxelBox) to support surgical planning and psychiatric diagnostics.

Delivering FDA-cleared, over-the-counter external trigeminal nerve stimulation to acutely treat and prevent migraines without drugs.

Evoking gamma brain waves via light and sound headset to slow Alzheimer’s progression, slowing cognitive decline, atrophy, and functional loss.

Implementing precision bioelectronic therapy with SOMA-1, an implant during glioblastoma surgery that continuously monitors and disrupts tumor-driving electrical signals.

Enabling mobile, high-density fNIRS brain imaging, used from labs to the ISS, tracking brain activity via oxygenation, multimodal interactions, and hyperscanning.

Delivered a sleep-improving EEG headband using real-time brain feedback and acoustic stimulation to enhance deep sleep and sleep quality.

Analyzing natural speech to detect depression and anxiety through empathetic AI voice agents, enabling scalable mental health screening.

Tapping into affective touch via gentle vibrations behind the ears to reduce stress and enhance sleep, transforming self-care into a scientifically grounded, feelable experience.

Pioneering ultrasound-based brain–computer interfaces using Forest 1, a compact, fob-sized scanner enabling noninvasive whole-brain imaging and neuromodulation.

Developing ultrathin graphene-based neural implants (<10 µm) for AI-powered, bidirectional modulation of neurological disorders like Parkinson’s.

Detecting signs of depression and anxiety from just seconds of speech, using AI-powered voice biomarkers to enhance mental health diagnosis.

Developing SAINT®, an image-guided, accelerated, non-invasive neuromodulation system targeting personalized brain networks to treat severe depression.

Exploring gene-therapy-enhanced, high-bandwidth, ultrasound-based brain-computer interfaces to enable seamless human–AI integration.

Developing ultra-efficient semiconductor chips that shrink and power neural implants, enabling scalable, minimally invasive brain therapies.

Developing minimally invasive, battery-free brain implants (DOT) that wirelessly stimulate brain circuits to treat treatment-resistant depression.

Extracting eye-movement biomarkers via AI and computer vision from standard webcams or smartphones to accelerate CNS drug development and neurology diagnostics.

Building FDA-cleared portable, robotic and AI-driven MRI platforms that bring real-time neuroimaging and interventional guidance directly to patients.

Providing Starstim and Enobio devices for wireless EEG monitoring and non-invasive brain stimulation, applied in research, clinical trials, and therapy.

Applying AI and mathematical modeling to EEG data to generate rapid, digital biomarkers that pinpoint seizure risk and support epilepsy diagnosis.

Equipping clinicians with a wearable, medical-grade EEG system that delivers real-time neural biomarkers via a head-adhered sensor and cloud analytics.

Developing FDA-cleared, non-invasive vestibular neurostimulation wearables (Modius Sleep, Modius Stress) to treat insomnia, anxiety, and metabolic disorders.

Developing AlphaDBS, a closed-loop deep brain stimulation implant that adapts therapy in real-time based on brain signals to treat Parkinson’s disease.

Open-source biosensing hardware (EEG/EMG/EKG) and Galea (EEG+biometrics for XR) for BCI research and developer tools.

Developing minimally invasive muscle implants and AI-driven interfaces enabling intuitive prosthetic and robotic limb control for amputees.

Empowering imaging teams with a cloud-native AI platform that automates MRI data upload, biomarker extraction, and centralized review for clinical trials.

Providing a cloud-based AI platform (StrivePD) that transforms smartphone and wearable neurology data into actionable insights for precision neurology.

Delivering a wearable audiovisual neuromodulation mask that uses light and sound pulses via HRV feedback to reduce chronic pain, improve sleep, and ease anxiety.

Delivers personalized, closed-loop rTMS-EEG neuromodulation (SinaptiStim) targeting the default mode network to slow Alzheimer's progression with Phase 2 clinical efficacy.

Developing FDA-cleared, wearable, non-invasive auricular neurostimulation (Sparrow Ascent) to provide drug-free relief for opioid withdrawal and other conditions.

Providing AI-powered enhancements for MRI and PET scanning, boosting image clarity, reducing scan time, and enabling dose minimization across all scanners.

Using 60 Hz non-invasive light stimulation via the eyes to trigger microglia-mediated neuroplasticity, offering a fast, drug-free option for depression and brain recovery.

Enabling non-invasive, VR headset-based assessment of neurocognitive health using eye movement biomarkers with high sensitivity and specificity.

Delivers adaptive, person-centred therapeutic music as medicine, supporting psychedelic therapy, ketamine sessions, breathwork, and psychotherapy.

Developing an adaptive, implantable neuromodulation device for women’s mixed urinary incontinence.

Empowering frontline EEG systems by transforming raw brain data into real-time, AI-powered clinical biomarkers.

Empowering multimodal brain–body research with wearable EEG and biosensor systems, backed by AI-powered data platforms.

Expanding access to neurological diagnostics by deploying portable EEG systems and telemedicine tools for remote epilepsy detection.

Pioneering wearable, wrist-based neuromodulation (TAPS) to reduce essential tremor by delivering patient-specific stimulation to the median and radial nerves.

Transforming CT and MRI scans into fully automated perfusion maps and advanced microvascular biomarkers to guide stroke and neuro-oncology care.

Empowering communication with a wireless AR headset that blends non-invasive EEG, AI, and augmented reality to help users speak and interact.

Delivering fast, non-invasive fNIRS brain scans with AI insights to track cognitive focus, memory, resilience, and longevity in real time.

Built a neural-interface wristband decoding hand-movement intent via sEMG, paving the way for gesture-free device control and AR/VR input (acquired by Meta).

Delivering a smart EEG brainband that tracks sleep, focus, and bio-signals in real time, and uses AI-driven audio feedback to enhance sleep and cognition.

Offering wireless, multi-channel EEG headsets and SDKs, empowering BCI research, emotion tracking, and hands-free control across diverse applications.

Offering an FDA-cleared cranial electrotherapy stimulator that non-invasively treats depression, anxiety, and insomnia via home use.

Delivering wearable, high-density fNIRS systems (LUMO & NTS) for 3D brain imaging in infants and adults across research and clinical settings globally.

Empowering meditation and mental fitness with wearable EEG headbands (Muse) that deliver real-time neurofeedback for focus, relaxation, and sleep.

Providing AI-powered video assessment of Parkinson’s motor symptoms, offering objective, reproducible metrics for clinical trials and care.

Delivering high-density microelectrode array platforms that record and stimulate neural cells in vitro, accelerating neuroscience and drug discovery.

Delivering a 12-week therapist-supported digital mental health program combining biofeedback, mindfulness, nutrition, and peer support via an app.

Transforming standard smartphones into AI-powered neurological test devices for remote motor, cognitive, and affective monitoring.

Offering affordable wireless EEG-based BCI tools, including Explorer, Emotions, and MindLace, for research, neurofeedback, and accessibility applications.

Developing high-channel-count implantable brain-computer interfaces to restore motor function, enable communication, and eventually merge humans with AI.

Passively monitoring brain health via AI-based keystroke and smartphone behavior analysis, delivering real-world neurological data non-invasively.

Delivers wearable, at-home neuromodulation via Relivion, stimulating multiple cranial nerve branches to relieve migraine and depression.

Offering a wearable EEG headset (the Crown) with AI-powered feedback that plays music to enhance focus, mindfulness, and mental state tracking.

Providing digital cognitive assessments that use eye-tracking and AI to deliver fast, validated screening for dementia and Alzheimer’s risk.

Empowering epilepsy and migraine patients with mobile apps (Helpilepsy, MigraineManager) for logging symptoms and safely sharing data with their neurologists.

Developing non-invasive EEG-based BCI headsets and a full-stack biosignal ecosystem, hardware, SDK, APIs, for real-time brain-tech interaction.

Developing wearable, open-source infrared and ultrasound platforms to diagnose and non-invasively treat diseases such as stroke, depression, and tumors.

Applying FDA-cleared, AI-powered analysis to brain MRI scans, enabling rapid lesion detection and volumetric quantification for neurological care.

Delivering AI-driven behavioral health care navigation and value-based care integration, matching patients to therapy and managing care across providers.

Develops invasive brain-machine interface systems for reconstructive therapy, aiming to restore neural control in conditions unresponsive to conventional options.

Offering an at-home neurofeedback headset combining EEG, transcranial photobiomodulation, and HRV biofeedback for personalized brain training.

Offering enterprise-ready AI voice biomarker SDKs for passive health monitoring across mental, cognitive, and respiratory wellbeing via everyday voice.

Building miniaturized, wireless, battery-free BCI chips enabling simultaneous stimulation and recording across multiple brain regions for future therapies.

Providing a behind-the-ear EEG wearable that non-invasively predicts blood glucose, sleep quality, and metabolic health via brain-signal analysis.

Offering Nerivio, a wearable, smartphone-controlled neuromodulation arm band that delivers drug-free, FDA-cleared relief and prevention for migraines.

Providing AI-powered EEG brain mapping software that enables point-of-care monitoring of dementia, correlating with amyloid, tau, atrophy, and cognitive endpoints.

Analyzing natural speech via tablet to extract vocal biomarkers that detect and monitor cognitive impairment, enabling objective, scalable assessments.